| Literature DB >> 31744626 |
Luan Firmino-Cruz1, Tadeu Diniz Ramos1, Alessandra Marcia da Fonseca-Martins1, Diogo Oliveira-Maciel1, Gabriel Oliveira-Silva1, Júlio Souza Dos Santos1, Cecília Cavazzoni1, Alexandre Morrot2, Daniel Claudio Oliveira Gomes3, André Macedo Vale1, Debora Decoté-Ricardo4, Celio G Freire-de-Lima1, Herbert Leonel de Matos Guedes5.
Abstract
Over the years research has found an association between B lymphocytes and pathogenesis during Leishmania sp. infections. Recently we demonstrated that B-2 lymphocytes are the main producers of IL-10 during L. amazonensis infection, and that the disease severity in BALB/c mice was attributed to these IL-10-producing B-2 lymphocytes. Here, we aim to understand the role of peritoneal B-1 lymphocytes in the pathogenesis of L. amazonensis infection. We found that infection resulted in a decrease in the number of B-1a lymphocytes and increase in B-1b lymphocytes in the peritoneal cavity of WT BALB/c mice but not in B lymphocyte deficient mice (BALB/Xid) mice. In vitro interaction between B-1 lymphocytes and L. amazonensis showed that the amastigote form of the parasite was able to induce higher levels of IL-10 in B-1 lymphocytes derived from infected BALB/c mice than the promastigote. Moreover, B-1 lymphocytes derived from infected mice produced more IL-10 than B-1 lymphocytes derived from naïve mice under amastigote interaction. However, the repopulation of BALB/Xid mice with B-1 lymphocytes from WT BALB/c mice did not affect the lesion development. Together, these results suggest that although B-1 lymphocytes are able to produce IL-10 during in vitro interaction with L. amazonensis, they are not directly related to pathogenesis in vivo.Entities:
Keywords: B-1; BALB/c; IL-10; Leishmania amazonensis; XID
Mesh:
Substances:
Year: 2019 PMID: 31744626 DOI: 10.1016/j.imbio.2019.10.006
Source DB: PubMed Journal: Immunobiology ISSN: 0171-2985 Impact factor: 3.144